The Role of bcl-2 in High Grade Gliomas
Author Information
Author(s): McDonald F E, Ironside J W, Gregor A, Wyatt B, Stewart M, Rye R, Adams J, Potts H W W
Primary Institution: Northern Centre for Cancer Treatment, Newcastle General Hospital
Hypothesis
This study aimed to evaluate the prognostic effect of bcl-2 in high grade gliomas.
Conclusion
The study found that the proportion of cells staining for bcl-2 is a significant prognostic factor for survival in high grade gliomas.
Supporting Evidence
- Age, histology, and performance status were strongly predictive of survival.
- Bcl-2 staining was independently predictive of overall survival.
- Intensity of bcl-2 staining did not predict survival.
- Median overall survival for the group was 10.3 months.
Takeaway
This study looked at how a protein called bcl-2 affects survival in brain tumors. It found that more bcl-2 means patients might live longer.
Methodology
The study reviewed clinicopathological features and bcl-2 expression in 187 high grade glioma patients, using immunostaining and statistical analysis.
Potential Biases
There may be sampling errors when selecting blocks for staining.
Limitations
Biopsies may be small and unrepresentative due to tumor heterogeneity.
Participant Demographics
Mean age was 51 years, with 61% male and 31% female.
Statistical Information
P-Value
0.0302
Confidence Interval
0.65–0.98
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website